AstraZeneca admits COVID vaccine can trigger rare side effect TTS - What is it? | The Federal
The Federal The Federal
26.3K subscribers
217 views
0

 Published On Apr 30, 2024

AstraZeneca, a prominent British-Swedish pharmaceutical company, has admitted in court that its COVID-19 vaccine, known as Covishield in India, carries the risk of a rare side effect called Thrombosis with Thrombocytopenia Syndrome (TTS).

#astrazeneca #astrazenecavaccine #covidvaccine

---
▶For more explainers, and interesting videos - thefederal.com/videos/ 
▶For the latest news and analysis - thefederal.com/ 
▶To watch The Federal's shows listed together for your easy access, click here:    • The Federal Programmes  

Follow The Federal News here -
▶Facebook:   / thefederal.india  
▶X: twitter.com/TheFederal_News
▶Instagram: instagram.com/thefederal_india/
▶LinkedIn:   / thefederal  
▶Whatsapp channel: https://www.whatsapp.com/channel/0029...
▶Threads: TheFederal India (@thefederal_india)

#BreakingNews #LatestNews #TodayNews #CurrentAffairs #News #IndiaNews #NewsToday #politics #exclusive #interviews #features

Download The Federal App here -
▶Android - http://bit.ly/TheFederalAndroid
▶iPhone - http://bit.ly/TheFederalios

show more

Share/Embed